Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-21-030988
Filing Date
2021-12-09
Accepted
2021-12-09 17:25:20
Documents
12
Period of Report
2021-07-03
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 31021
  Complete submission text file 0001493152-21-030988.txt   206210

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qlgn-20210703.xsd EX-101.SCH 3034
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qlgn-20210703_lab.xml EX-101.LAB 34916
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qlgn-20210703_pre.xml EX-101.PRE 22795
5 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 3760
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37428 | Film No.: 211482885
SIC: 2834 Pharmaceutical Preparations